Trademark: 98241205
Word
TECELRA
Status Date
Wednesday, November 1, 2023
Filing Date
Thursday, October 26, 2023
9 Cell therapy pharmaceutical preparations; immunotherapy preparations; T-cell receptors; immunotherapy preparations comprising engineered T-cell receptors; immunotherapy preparations comprising genes encoding engineered T-cell receptors
44 Cell therapy medical treatment services; immunotherapy services; medical treatment and immune-therapy comprising harvesting a patient's white blood cells, combining white blood cells with an engineered T-cell receptor therapeutic, transducing the white blood cells with the gene encoding the engineered T-cell receptor and infusion of the transduced white blood cells back into the patient
The mark consists of the term "TECELRA" with a stylized depiction of.
Color is not claimed as a feature of the mark.
Nov 2, 2023
Notice Of Design Search Code E-Mailed
Nov 1, 2023
New Application Office Supplied Data Entered
Oct 30, 2023
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
